
Raghuzime 125mg Injection
Marketer
Godrams Lifeline
Salt Composition
Ceftazidime (125mg)
Overview Raghuzime 125mg Injection
Cefazolin 125mg Injection combats bacterial infections throughout the body. Its efficacy extends to infections affecting the brain, lungs, ears, urinary tract, skin, soft tissues, bones, joints, blood, and heart. Prophylactic use is also indicated before surgical procedures. This antibiotic inhibits bacterial growth, alleviating symptoms and resolving the underlying infection. Administered intravenously (IV drip) or via intramuscular injection by a healthcare professional, dosage is determined by your physician. Consistent, evenly-spaced dosing, as directed, is crucial; premature cessation risks relapse or infection exacerbation. Common side effects may include skin rash and diarrhea; localized injection site redness or pain may also occur temporarily. Report persistent or bothersome side effects to your doctor. Prior to use, disclose any antibiotic allergies, liver or kidney issues, and all other medications you are currently taking to your doctor or healthcare provider. Consult your doctor before use if pregnant or breastfeeding.
Primary Ingredients of Raghuzime 125mg Injection
No text was provided. Therefore, no rephrased text can be provided.
Uses of Raghuzime 125mg Injection
Infections caused by bacteria
Major Benefits of Raghuzime 125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Raghuzime 125mg Injection:
- Rash
- Allergic reaction
- Injection site reaction
- Diarrhea
How to use Raghuzime 125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Raghuzime 125mg Injection works:
Raghuzime 125mg Injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thus preventing bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside a 125mg dose of Raghuzime Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Raghuzime, 125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials are currently scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Raghuzime 125mg is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the drug into breast milk, posing no apparent risk to the infant. However, extended use of Raghuzime 125mg Injection should be avoided due to potential side effects including skin rash and diarrhea.
DrivingUNSAFE
Administering Raghuzime 125mg Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, administering Raghuzime 125mg Injection requires careful consideration. Dosage modification of Raghuzime 125mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Raghuzime 125mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment. Dosage modification of Raghuzime 125mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Raghuzime 125mg Injection :
Omit a dose of Raghuzime 125mg Injection? Seek your physician's advice.
Facts to Know About Raghuzime 125mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-spectrum cephalosporins (generations 3 and 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Third-generation cephalosporins |
